Factors governing HIV-1 persistence in vivo. NLM AIDSLINE Important note: Information in this article was accurate in 1991. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Factors governing HIV-1 persistence in vivo.

Int Conf AIDS. 1991 Jun 16-21;7(1):21 (abstract no. M.A.6). Unique Identifier : AIDSLINE ICA7/1000691
Stevenson M; Bukrinsky MI; Stanwick TL; Dempsey MP; Department of Pathology and Microbiology, University of Nebraska; Medical Center, Omaha, NE USA


Abstract: The underlying basis for HIV-1 persistence and latency and the nature of the virus reservoir in the course of AIDS remains unresolved. The large number of cells in infected individuals which harbor proviral DNA is difficult to reconcile with low numbers of productively infected cells suggesting a restricted reservoir where a majority of infected cells are non-permissive to a complete HIV-1 replication cycle. Our previous work in vitro has demonstrated that quiescent T lymphocytes are infectible by HIV-1 with equal efficiency when compared to activated lymphocytes, although the virus life cycle is restricted due to an as yet unidentified block to HIV-1 integration. Importantly, the preintegration complex within quiescent lymphocytes retains full capacity to integrate upon subsequent activation of the infected host cell. These in vitro experiments prompted us to determine whether infected quiescent lymphocytes represent a reservoir for HIV-1 in vivo and whether this reservoir could explain some of the features of viral persistence in AIDS. We have developed a PCR protocol which allows us to distinguish a single copy of the HIV-1 genome and to determine whether viral DNA is in an integrated or unintegrated state. Application of this method to analysis of lymphocytes from a cohort of HIV-1 infected asymptomatic and AIDS individuals demonstrated that a major portion of viral DNA in asymptomatic individuals exists as full length unintegrated HIV-1 genomes. In contrast, the major DNA form in AIDS patients was an integrated provirus. Importantly, in vitro activation of lymphocytes from asymptomatic individuals resulted in efficient integration of viral DNA demonstrating an inducible virus reservoir. Several lines of evidence, including ligation mediated PCR analysis of patient lymphocyte subpopulations depleted of activated cells, specifically identified quiescent T lymphocytes as the source of extrachromosomal HIV-1 DNA. Our data demonstrates the existence of a novel HIV-1 reservoir in infected individuals. The nature of this novel quiescent T lymphocyte reservoir indicates that HIV-1 latency and persistence is governed in part by events prior to proviral integration.
Keywords: Acquired Immunodeficiency Syndrome/IMMUNOLOGY DNA, Viral Genes, Viral Human HIV-1/GENETICS/*PHYSIOLOGY Lymphocyte Transformation T-Lymphocytes/MICROBIOLOGY ABSTRACTKWDacquiredimmunodeficiencysyndrome/immunologydna,viralgenes,viralhumanhiv-1/genetics/KWDphysiologylymphocytetransformationt-lymphocytes/microbiologyabstract
912130
M91C4063

Copyright © 1991 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .